(daratumumab and hyaluronidase-fihj)
Medical inquiries
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)
Medical Information
Can I Take DARZALEX or DARZALEX FASPRO if I Have Coronavirus Disease 2019 (COVID-19)?
Last Updated: 03/11/2024
The following information is provided in response to your specific unsolicited request and is not intended as an endorsement of any usage not contained in the Package Insert. Please review this information with your healthcare provider to address any specifics regarding your treatment.
There is currently no specific information available for use of DARZALEX/DARZALEX FASPRO in patients with coronavirus disease (COVID-19).
summary
Product Labeling
DARZALEX (daratumumab) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.; https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/DARZALEX-pi.pdf - DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.; https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/DARZALEX+Faspro-pi.pdf
Below is a list of selected publicly available resources pertaining to this topic.
- For information from the U.S. Centers for Disease Control and Prevention (CDC), visit: Coronavirus (COVID-19).
- For information from the U.S. Food and Drug Administration (FDA), visit: Coronavirus Disease 2019 (COVID-19).
- For information from the World Health Organization (WHO), visit: Coronavirus disease (COVID-19) pandemic.
- For information from the American Cancer Society (ACS), visit: Coronavirus, COVID-19, and Cancer.
This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.